ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer

Hashimoto, Shigeru, Furukawa, Shotaro, Hashimoto, Ari · Proceedings of the National Academy of Sciences · 2019